1K0

2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxyquinazolin-4(3H)-one

Created:	2013-02-25
Last modified:	2013-11-27

Find Related PDB Entry
6 entries where 1K0 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	49
Chiral Atom Count	0
Bond Count	51
Aromatic Bond Count	12

2D diagram of 1K0

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxyquinazolin-4(3H)-one
Systematic Name (OpenEye OEToolkits)	2-[4-(2-hydroxyethyloxy)-3,5-dimethyl-phenyl]-5,7-dimethoxy-3H-quinazolin-4-one
Formula	C₂₀ H₂₂ N₂ O₅
Molecular Weight	370.399
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C2c3c(N=C(c1cc(c(OCCO)c(c1)C)C)N2)cc(OC)cc3OC
SMILES	CACTVS	3.370	COc1cc(OC)c2C(=O)NC(=Nc2c1)c3cc(C)c(OCCO)c(C)c3
SMILES	OpenEye OEToolkits	1.7.6	Cc1cc(cc(c1OCCO)C)C2=Nc3cc(cc(c3C(=O)N2)OC)OC
Canonical SMILES	CACTVS	3.370	COc1cc(OC)c2C(=O)NC(=Nc2c1)c3cc(C)c(OCCO)c(C)c3
Canonical SMILES	OpenEye OEToolkits	1.7.6	Cc1cc(cc(c1OCCO)C)C2=Nc3cc(cc(c3C(=O)N2)OC)OC
InChI	InChI	1.03	InChI=1S/C20H22N2O5/c1-11-7-13(8-12(2)18(11)27-6-5-23)19-21-15-9-14(25-3)10-16(26-4)17(15)20(24)22-19/h7-10,23H,5-6H2,1-4H3,(H,21,22,24)
InChIKey	InChI	1.03	NETXMUIMUZJUTB-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank ID	DB12000
Name	Apabetalone
Groups	investigational
Description	Apabetalone has been investigated for the treatment of Diabetes, Atherosclerosis, and Coronary Artery Disease.
Synonyms	Apabetalone
Categories	Heterocyclic Compounds, Fused-Ring Quinazolines
CAS number	1044870-39-4

Related Resource References

Resource Name	Reference
Pharos	CHEMBL2393130
PubChem	24871506, 135564749
ChEMBL	CHEMBL2393130
CCDC/CSD	EWOJOS, EXACEO, EWOJOS01

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.